Association between glycemic control, age, and outcomes among intensively treated patients with acute myeloid leukemia

[1]  D. Von Ah,et al.  Impact of Hyperglycemia and Age on Outcomes in Patients With Acute Myeloid Leukemia. , 2016, Oncology nursing forum.

[2]  S. Isom,et al.  Comorbidity, age, and mortality among adults treated intensively for acute myeloid leukemia (AML). , 2016, Journal of geriatric oncology.

[3]  I. Hirsch.  Glycemic Variability and Diabetes Complications: Does It Matter? Of Course It Does! , 2015, Diabetes Care.

[4]  D. Von Ah,et al.  Prevalence and impact of hyperglycemia on hospitalized leukemia patients. , 2015, European journal of oncology nursing : the official journal of European Oncology Nursing Society.

[5]  Daniel J Weisdorf,et al.  Acute Myeloid Leukemia. , 2015, The New England journal of medicine.

[6]  S. Juo,et al.  High glucose modulates antiproliferative effect and cytotoxicity of 5-fluorouracil in human colon cancer cells. , 2014, DNA and cell biology.

[7]  J. Callés-Escandon,et al.  Increased Glycemic Variability Is Independently Associated With Length of Stay and Mortality in Noncritically Ill Hospitalized Patients , 2013, Diabetes Care.

[8]  D. Gillatt,et al.  Hyperglycaemia-induced chemoresistance of prostate cancer cells due to IGFBP2. , 2013, Endocrine-related cancer.

[9]  E. Kilpatrick,et al.  Glycemic Variability: Both Sides of the Story , 2013, Diabetes Care.

[10]  M. Lübbert,et al.  Parameters detected by geriatric and quality of life assessment in 195 older patients with myelodysplastic syndromes and acute myeloid leukemia are highly predictive for outcome , 2013, Haematologica.

[11]  V. Lima,et al.  Hyperglycemia increases the complicated infection and mortality rates during induction therapy in adult acute leukemia patients , 2013, Revista brasileira de hematologia e hemoterapia.

[12]  D. Weisdorf,et al.  Survival for older patients with acute myeloid leukemia: a population-based study , 2012, Haematologica.

[13]  A. Savic,et al.  The hematopoietic cell transplantation comorbidity index is a predictor of early death and survival in adult acute myeloid leukemia patients. , 2012, Leukemia research.

[14]  M. Ihnat,et al.  ‘Glycaemic variability’: a new therapeutic challenge in diabetes and the critical care setting , 2010, Diabetic medicine : a journal of the British Diabetic Association.

[15]  L. Zeng,et al.  Hyperglycaemia confers resistance to chemotherapy on breast cancer cells: the role of fatty acid synthase. , 2010, Endocrine-related cancer.

[16]  Bob Löwenberg,et al.  Review Articles (434 articles) , 2008 .

[17]  J. Krinsley,et al.  Glycemic variability: A strong independent predictor of mortality in critically ill patients* , 2008, Critical care medicine.

[18]  M. Grever,et al.  Hyperglycemia in patients with acute myeloid leukemia is associated with increased hospital mortality , 2007, Cancer.

[19]  B. Esterni,et al.  Comorbidity is an independent predictor of complete remission in elderly patients receiving induction chemotherapy for acute myeloid leukemia , 2007, Cancer.

[20]  K. Clément,et al.  Acute Hyperglycemia Induces a Global Downregulation of Gene Expression in Adipose Tissue and Skeletal Muscle of Healthy Subjects , 2007, Diabetes.

[21]  H. Kantarjian,et al.  The haematopoietic cell transplantation comorbidity index score is predictive of early death and survival in patients over 60 years of age receiving induction therapy for acute myeloid leukaemia. , 2007, British journal of haematology.

[22]  Rinaldo Bellomo,et al.  Variability of Blood Glucose Concentration and Short-term Mortality in Critically Ill Patients , 2006, Anesthesiology.

[23]  A. Ceriello,et al.  Constant and intermittent high glucose enhances endothelial cell apoptosis through mitochondrial superoxide overproduction , 2006, Diabetes/metabolism research and reviews.

[24]  H. Gundacker,et al.  Age and acute myeloid leukemia. , 2006, Blood.

[25]  A. Ceriello,et al.  Intermittent high glucose enhances ICAM-1, VCAM-1 and E-selectin expression in human umbilical vein endothelial cells in culture: the distinct role of protein kinase C and mitochondrial superoxide production. , 2005, Atherosclerosis.

[26]  D. Giugliano,et al.  Intermittent high glucose enhances ICAM‐1, VCAM‐1, E‐selectin and interleukin‐6 expression in human umbilical endothelial cells in culture: the role of poly(ADP‐ribose) polymerase , 2004, Journal of thrombosis and haemostasis : JTH.

[27]  E. Bonora,et al.  Long-term instability of fasting plasma glucose predicts mortality in elderly NIDDM patients: the Verona Diabetes Study , 1995, Diabetologia.

[28]  C. Bloomfield,et al.  Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  Antonio Ceriello,et al.  Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation. , 2003, Diabetes.

[30]  H. Kantarjian,et al.  Acute myeloid leukemia , 2018, Methods in Molecular Biology.

[31]  M. Slovak,et al.  Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study , 2000 .

[32]  R. de Marco,et al.  Long-term instability of fasting plasma glucose, a novel predictor of cardiovascular mortality in elderly patients with non-insulin-dependent diabetes mellitus: the Verona Diabetes Study. , 1997, Circulation.